Healthpeak Properties, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$467.46M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: DOC stock price vs CXW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CXW's multiple
Needs CXW P/E.
Implied fair value · at DOC's multiple
Needs DOC P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
11 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Healthpeak Properties, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
CORECIVIC, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
WELLTOWER INC.
DOC vs WELL
Ventas, Inc.
DOC vs VTR
ALEXANDRIA REAL ESTATE EQUITIES, INC.
DOC vs ARE
SL GREEN REALTY CORP
DOC vs SLG
GEO GROUP INC
DOC vs GEO
NATIONAL HEALTH INVESTORS INC
DOC vs NHI
AMERICAN TOWER CORP /MA/
DOC vs AMT
EQUINIX INC
DOC vs EQIX
Public Storage
DOC vs PSA
Extra Space Storage Inc.
DOC vs EXR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe DOC can materially improve earnings conversion and cut leverage toward CXW-like levels, then the valuation premium may be defensible; otherwise, the data supports avoiding or underweighting DOC because its current price implies a multiple expansion that is not supported by its slower growth, weaker net margins, and 14.5x net debt/EBITDA.
DOC trades at a very large valuation premium to CXW despite weaker earnings and balance-sheet metrics. The gap is especially stark on P/E, EV/EBITDA, and EV/Revenue, and the current price sits near the top of DOC’s historical band rather than near the cheaper CXW-implied or DCF ranges.
Supporting Metrics